The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Attention Deficit Disorder with Hyperactivity

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Attention Deficit Disorder with Hyperactivity


Psychiatry related information on Attention Deficit Disorder with Hyperactivity


High impact information on Attention Deficit Disorder with Hyperactivity


Chemical compound and disease context of Attention Deficit Disorder with Hyperactivity


Biological context of Attention Deficit Disorder with Hyperactivity


Anatomical context of Attention Deficit Disorder with Hyperactivity


Gene context of Attention Deficit Disorder with Hyperactivity


Analytical, diagnostic and therapeutic context of Attention Deficit Disorder with Hyperactivity


  1. Catechol O-methyltransferase gene variant and birth weight predict early-onset antisocial behavior in children with attention-deficit/hyperactivity disorder. Thapar, A., Langley, K., Fowler, T., Rice, F., Turic, D., Whittinger, N., Aggleton, J., Van den Bree, M., Owen, M., O'Donovan, M. Arch. Gen. Psychiatry (2005) [Pubmed]
  2. Methylphenidate-induced chorea: case report and pharmacologic implications. Weiner, W.J., Nausieda, P.A., Klawans, H.L. Neurology (1978) [Pubmed]
  3. Association between attention-deficit/hyperactivity disorder and bulimia nervosa: analysis of 4 case-control studies. Surman, C.B., Randall, E.T., Biederman, J. The Journal of clinical psychiatry. (2006) [Pubmed]
  4. Coloboma hyperactive mutant mice exhibit regional and transmitter-specific deficits in neurotransmission. Raber, J., Mehta, P.P., Kreifeldt, M., Parsons, L.H., Weiss, F., Bloom, F.E., Wilson, M.C. J. Neurochem. (1997) [Pubmed]
  5. Catecholamine functioning in children with traumatic brain injuries and children with attention-deficit/hyperactivity disorder. Konrad, K., Gauggel, S., Schurek, J. Brain research. Cognitive brain research. (2003) [Pubmed]
  6. Parent-child conflict and the comorbidity among childhood externalizing disorders. Burt, S.A., Krueger, R.F., McGue, M., Iacono, W. Arch. Gen. Psychiatry (2003) [Pubmed]
  7. Psychiatric diagnoses of treatment-seeking cocaine abusers. Rounsaville, B.J., Anton, S.F., Carroll, K., Budde, D., Prusoff, B.A., Gawin, F. Arch. Gen. Psychiatry (1991) [Pubmed]
  8. Suicidality in pediatric patients treated with antidepressant drugs. Hammad, T.A., Laughren, T., Racoosin, J. Arch. Gen. Psychiatry (2006) [Pubmed]
  9. A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder. Spencer, T., Biederman, J., Coffey, B., Geller, D., Crawford, M., Bearman, S.K., Tarazi, R., Faraone, S.V. Arch. Gen. Psychiatry (2002) [Pubmed]
  10. Neurologic soft signs in chronic posttraumatic stress disorder. Gurvits, T.V., Gilbertson, M.W., Lasko, N.B., Tarhan, A.S., Simeon, D., Macklin, M.L., Orr, S.P., Pitman, R.K. Arch. Gen. Psychiatry (2000) [Pubmed]
  11. Blood serotonin levels in the attention-deficit disorder. Haslam, R.H., Dalby, J.T. N. Engl. J. Med. (1983) [Pubmed]
  12. Selective brain dopamine depletion in developing rats: an experimental model of minimal brain dysfunction. Shaywitz, B.A., Yager, R.D., Klopper, J.H. Science (1976) [Pubmed]
  13. A dynamic developmental theory of attention-deficit/hyperactivity disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes. Sagvolden, T., Johansen, E.B., Aase, H., Russell, V.A. The Behavioral and brain sciences. (2005) [Pubmed]
  14. JAMA patient page. Attention-deficit/hyperactivity disorder. Parmet, S. JAMA (2002) [Pubmed]
  15. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. Goldman, L.S., Genel, M., Bezman, R.J., Slanetz, P.J. JAMA (1998) [Pubmed]
  16. Levoamphetamine vs dextroamphetamine in minimal brain dysfunction. Replication, time response, and differential effect by diagnostic group and family rating. Arnold, L.E., Huestis, R.D., Smeltzer, D.J., Scheib, J., Wemmer, D., Colner, G. Arch. Gen. Psychiatry (1976) [Pubmed]
  17. Pemoline, methylphenidate, and placebo in children with minimal brain dysfunction. Conners, C.K., Taylor, E. Arch. Gen. Psychiatry (1980) [Pubmed]
  18. Methylphenidate and children with attention deficit disorder. Dose effects on classroom academic and social behavior. Pelham, W.E., Bender, M.E., Caddell, J., Booth, S., Moorer, S.H. Arch. Gen. Psychiatry (1985) [Pubmed]
  19. Methylphenidate vs dextroamphetamine vs caffeine in minimal brain dysfunction: controlled comparison by placebo washout design with Bayes' analysis. Arnold, L.E., Christopher, J., Huestis, R., Smeltzer, D.J. Arch. Gen. Psychiatry (1978) [Pubmed]
  20. Effects of renal clearance on plasma concentrations of homovanillic acid. Methodologic cautions. Potter, W.Z., Hsiao, J.K., Goldman, S.M. Arch. Gen. Psychiatry (1989) [Pubmed]
  21. A common haplotype of the dopamine transporter gene associated with attention-deficit/hyperactivity disorder and interacting with maternal use of alcohol during pregnancy. Brookes, K.J., Mill, J., Guindalini, C., Curran, S., Xu, X., Knight, J., Chen, C.K., Huang, Y.S., Sethna, V., Taylor, E., Chen, W., Breen, G., Asherson, P. Arch. Gen. Psychiatry (2006) [Pubmed]
  22. Attention deficit/hyperactivity disorder children with a 7-repeat allele of the dopamine receptor D4 gene have extreme behavior but normal performance on critical neuropsychological tests of attention. Swanson, J., Oosterlaan, J., Murias, M., Schuck, S., Flodman, P., Spence, M.A., Wasdell, M., Ding, Y., Chi, H.C., Smith, M., Mann, M., Carlson, C., Kennedy, J.L., Sergeant, J.A., Leung, P., Zhang, Y.P., Sadeh, A., Chen, C., Whalen, C.K., Babb, K.A., Moyzis, R., Posner, M.I. Proc. Natl. Acad. Sci. U.S.A. (2000) [Pubmed]
  23. A genome-wide scan for attention-deficit/hyperactivity disorder in 155 German sib-pairs. Hebebrand, J., Dempfle, A., Saar, K., Thiele, H., Herpertz-Dahlmann, B., Linder, M., Kiefl, H., Remschmidt, H., Hemminger, U., Warnke, A., Knölker, U., Heiser, P., Friedel, S., Hinney, A., Schäfer, H., Nürnberg, P., Konrad, K. Mol. Psychiatry (2006) [Pubmed]
  24. Functional neuroimaging of attention-deficit/hyperactivity disorder: a review and suggested future directions. Bush, G., Valera, E.M., Seidman, L.J. Biol. Psychiatry (2005) [Pubmed]
  25. Neuropsychologic theory and findings in attention-deficit/hyperactivity disorder: the state of the field and salient challenges for the coming decade. Nigg, J.T. Biol. Psychiatry (2005) [Pubmed]
  26. Functional brain electrical activity mapping in boys with attention-deficit/hyperactivity disorder. Silberstein, R.B., Farrow, M., Levy, F., Pipingas, A., Hay, D.A., Jarman, F.C. Arch. Gen. Psychiatry (1998) [Pubmed]
  27. Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Arnsten, A.F., Li, B.M. Biol. Psychiatry (2005) [Pubmed]
  28. Cerebrospinal fluid homovanillic acid predicts behavioral response to stimulants in 45 boys with attention deficit/hyperactivity disorder. Castellanos, F.X., Elia, J., Kruesi, M.J., Marsh, W.L., Gulotta, C.S., Potter, W.Z., Ritchie, G.F., Hamburger, S.D., Rapoport, J.L. Neuropsychopharmacology (1996) [Pubmed]
  29. Thyroid function tests and neurocognitive functioning in children referred for attention deficit/hyperactivity disorder. Stein, M.A., Weiss, R.E. Psychoneuroendocrinology (2003) [Pubmed]
  30. Implication of right frontostriatal circuitry in response inhibition and attention-deficit/hyperactivity disorder. Casey, B.J., Castellanos, F.X., Giedd, J.N., Marsh, W.L., Hamburger, S.D., Schubert, A.B., Vauss, Y.C., Vaituzis, A.C., Dickstein, D.P., Sarfatti, S.E., Rapoport, J.L. Journal of the American Academy of Child and Adolescent Psychiatry. (1997) [Pubmed]
  31. Evidence of positive selection acting at the human dopamine receptor D4 gene locus. Ding, Y.C., Chi, H.C., Grady, D.L., Morishima, A., Kidd, J.R., Kidd, K.K., Flodman, P., Spence, M.A., Schuck, S., Swanson, J.M., Zhang, Y.P., Moyzis, R.K. Proc. Natl. Acad. Sci. U.S.A. (2002) [Pubmed]
  32. Joint analysis of the DRD5 marker concludes association with attention-deficit/hyperactivity disorder confined to the predominantly inattentive and combined subtypes. Lowe, N., Kirley, A., Hawi, Z., Sham, P., Wickham, H., Kratochvil, C.J., Smith, S.D., Lee, S.Y., Levy, F., Kent, L., Middle, F., Rohde, L.A., Roman, T., Tahir, E., Yazgan, Y., Asherson, P., Mill, J., Thapar, A., Payton, A., Todd, R.D., Stephens, T., Ebstein, R.P., Manor, I., Barr, C.L., Wigg, K.G., Sinke, R.J., Buitelaar, J.K., Smalley, S.L., Nelson, S.F., Biederman, J., Faraone, S.V., Gill, M. Am. J. Hum. Genet. (2004) [Pubmed]
  33. Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Beaulieu, J.M., Sotnikova, T.D., Yao, W.D., Kockeritz, L., Woodgett, J.R., Gainetdinov, R.R., Caron, M.G. Proc. Natl. Acad. Sci. U.S.A. (2004) [Pubmed]
  34. Genetic linkage of attention-deficit/hyperactivity disorder on chromosome 16p13, in a region implicated in autism. Smalley, S.L., Kustanovich, V., Minassian, S.L., Stone, J.L., Ogdie, M.N., McGough, J.J., McCracken, J.T., MacPhie, I.L., Francks, C., Fisher, S.E., Cantor, R.M., Monaco, A.P., Nelson, S.F. Am. J. Hum. Genet. (2002) [Pubmed]
  35. Fenfluramine and dextroamphetamine treatment of childhood hyperactivity. Clinical and biochemical findings. Donnelly, M., Rapoport, J.L., Potter, W.Z., Oliver, J., Keysor, C.S., Murphy, D.L. Arch. Gen. Psychiatry (1989) [Pubmed]
  36. Methylphenidate and caffeine in the treatment of children with minimal brain dysfunction. Garfinkel, B.D., Webster, C.D., Sloman, L. The American journal of psychiatry. (1975) [Pubmed]
  37. Pemoline in attention deficit disorder and alcoholism: a case study. Turnquist, K., Frances, R., Rosenfeld, W., Mobarak, A. The American journal of psychiatry. (1983) [Pubmed]
  38. Attention-deficit/hyperactivity disorder pharmacogenomics. McGough, J.J. Biol. Psychiatry (2005) [Pubmed]
  39. Electroencephalogram differences in two subtypes of attention-deficit/hyperactivity disorder. Clarke, A.R., Barry, R.J., McCarthy, R., Selikowitz, M. Psychophysiology. (2001) [Pubmed]
WikiGenes - Universities